Leo Creative

  • Home
  • About
  • Our Approach
  • Our Work
    • Branding
    • Healthcare
  • Contact

Launching a new treatment for Dupuytren’s contracture

Client: Janssen Australia

dupuytens

Leo Creative worked with Janssen on the Australian launch of collagenase – a non-surgical TGA approved treatment for Dupuytren’s contracture. Like most pharma branding, the creative was done overseas, so the task was to adapt global brand assets for the local Australia market.

A wide range of collateral was produced including mandatory items like product information and consumer medicine information, printed detail aid and e-detailer (Veeva iRep), physician and patient guides.

Filed Under: work

An online resource for AbbVie’s Virology Sales Team

Client: AbbVie Australia AbbVie approached Leo Creative with a specific problem. In a highly competitive environment and an abundance of existing and new research, how can we ensure our in-field … MORE

PAH Clinic

Client: Janssen Australia Janssen is a global leader in the science and medicine of Pulmonary Arterial Hypertension having launched the first endothelin receptor antagonist (ERA) bostentan, … MORE

A new brand story for Barker College

An audit of Barker College’s advertising and a review of quant and qual research led to a new brand story for Barker College. Following the successful delivery of a new enrolment prospectus, Barker … MORE

Veeva iRep v Next Interact

After delivering our first project targeting Veeva’s iRep platform, here are some initial thoughts on creating content for these two widely used apps. In many ways comparing Next Interact with Veeva … MORE

Copyright © 2026 Leo Creative Pty Ltd · Genesis Framework by StudioPress · Log in